| Literature DB >> 35877703 |
Siwen Niu1, Shuhuan Huang1, Bihong Hong1, Qixi Huang2, Xiupian Liu1, Zongze Shao1, Gaiyun Zhang1.
Abstract
Four novel monocyclic cyclopropane acids, namely, sydocyclopropanes A-D (1-4), along with one known congener hamavellone B (5), were isolated from the Aspergillus sydowii MCCC 3A00324 fungus, which was isolated from the deep-sea sediment. The gross structures of novel compounds were established by detailed analyses of the spectroscopic data (HRESIMS and NMR spectra), and their absolute configurations were resolved on the basis of the quantum chemical calculations of ECD and NMR data, in association with DP4+ probability analyses. Sydocyclopropanes A-D, featuring the 1,1,2,3-tetrasubstituted cyclopropane nucleus with different lengthy alkyl side chains, were discovered in nature for the first time. All compounds exhibited antiviral activities against A/WSN/33 (H1N1), with IC50 values ranging from 26.7 to 77.2 μM, of which compound 1 exhibited a moderate inhibitory effect (IC50 = 26.7 μM).Entities:
Keywords: Aspergillus sydowii; H1N1; antiviral activities; cyclopropane; deep-sea-derived fungus
Mesh:
Substances:
Year: 2022 PMID: 35877703 PMCID: PMC9321810 DOI: 10.3390/md20070410
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Chemical structures of the isolated metabolites 1–5.
1H NMR spectroscopic data of 1–4 recorded at 400 MHz in CD3OD (δ in ppm, J in Hz).
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 2 | 0.93, m | 0.99, m | 0.81, m | 1.53, m |
| 3 | 1.51, q (7.1) | 1.81, q (7.2) | 1.36, q (7.1) | 1.43, dt (9.5, 7.3) |
| 4 | 1.64, m | 2.46, dd (16.7, 7.3); | 1.65, m | 1.59, m |
| 5 | 2.57, t (7.4) | 2.60, t (7.3) | 2.58, t (7.5) | |
| 6 | 1.04, d (5.6) | |||
| 7 | 2.16, s | 1.43, s | 2.17, s | 2.17, s |
| 8 | 0.98, d (5.8) | 1.16, d (6.2) | 1.03, d (6.5) | |
| 9 | 1.43, s | 2.27, s | 1.28, s | 1.15, s |
| 11 | 3.14, dd (17.8, 4.3); | |||
| 12 | 4.51, dd (6.6, 4.3) | |||
| OCH3 | 3.73, s |
13C NMR spectroscopic data of 1–4 in CD3OD (100 MHz).
| No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| 1 | 36.9, C | 36.5, C | 29.2, C | 25.5, C |
| 2 | 34.9, CH | 33.9, CH | 31.5, CH | 24.3, CH |
| 3 | 33.0, CH | 29.2, CH | 32.8, CH | 29.7, CH |
| 4 | 24.1, CH2 | 34.4, CH2 | 24.1, CH2 | 18.7, CH2 |
| 5 | 44.0, CH2 | 176.6, C | 44.0, CH2 | 43.7, CH2 |
| 6 | 211.5, C | 12.0, CH3 | 211.5, C | 211.3, C |
| 7 | 30.0, CH3 | 16.5, CH3 | 29.9, CH3 | 29.9, CH3 |
| 8 | 12.3, CH3 | 211.2, C | 13.0, CH3 | 7.8, CH3 |
| 9 | 15.6, CH3 | 29.6, CH3 | 15.7, CH3 | 8.7, CH3 |
| 10 | 209.1, C | 178.1, C | 180.7, C | |
| 11 | 46.2, CH2 | |||
| 12 | 67.9, CH | |||
| 13 | 175.9, C | |||
| OCH3 | 52.6, CH3 |
Figure 2COSY () and key HMBC () correlations of 1–3.
Figure 3Key NOESY correlations of compounds 1–4.
Figure 4Experimental ECD spectrum of 1 in MeOH and the calculated ECD data of (1S,2S,3S)−1 and (1R,2R,3R)−1 at the B3LYP/6−311G(2d,p) level.
Figure 5Experimental and calculated ECD spectra of 2.
Figure 6Experimental and calculated ECD data of 3.
Figure 7Experimental and calculated ECD spectra of 4.
Inhibitory activities of 1–5 against influenza virus A/WSN/33 (H1N1).
| Compounds | IC50 (μM) | CC50 (μM) |
|---|---|---|
|
| 26.7 ± 0.9 | >100 |
|
| 29.5 ± 1.4 | >100 |
|
| 77.2 ± 0.5 | >100 |
|
| 66.4 ± 1.7 | >100 |
|
| 35.8 ± 3.2 | >100 |
| OSV | 18.1 ± 1.2 | >100 |